Case Report
Accepted on 10 Oct 2024
Response to furmonertinib in a patient with non-small cell lung cancer harboring HER2 exon 21 insertion mutation: A case report
in Cancer Molecular Targets and Therapeutics
Case Report
Accepted on 10 Oct 2024
in Cancer Molecular Targets and Therapeutics
Opinion
Accepted on 10 Oct 2024
in Regulatory Science
Case Report
Accepted on 10 Oct 2024
in Pediatric Surgery
Review
Accepted on 10 Oct 2024
in Translational Pharmacology
Perspective
Accepted on 10 Oct 2024
in Quantum Information Theory
Original Research
Accepted on 10 Oct 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 10 Oct 2024
in Clinical Nutrition
Original Research
Accepted on 10 Oct 2024
in Aging and Public Health
Case Report
Accepted on 10 Oct 2024
in Thoracic Oncology
Original Research
Accepted on 10 Oct 2024
in Comparative and Clinical Medicine
Original Research
Accepted on 10 Oct 2024
in Higher Education
Original Research
Accepted on 10 Oct 2024
in Nutrition and Microbes
Original Research
Accepted on 10 Oct 2024
in Phage Biology
Original Research
Accepted on 10 Oct 2024
in Vaccines and Molecular Therapeutics
Original Research
Accepted on 10 Oct 2024
in Technical Advances in Plant Science
Original Research
Accepted on 10 Oct 2024
in Biogeography and Macroecology